The BMI and the frequency of obesity in patients with no AMPD1 activity were significantly lower compared to other patients (e.g., patients with full or intermediate activity of AMP deaminase 1). This evidence concerns the gene AMPD1 and obesity due to melanocortin 4 receptor deficiency.